|
Aug 8
|
Tandem, Insulet monitoring CMS payment proposal for diabetes tech
|
|
Aug 7
|
S&P 500 Gains and Losses Today: Apple Stock Climbs; Eli Lilly Slumps After Disappointing Trial Results
|
|
Aug 7
|
Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars
|
|
Aug 7
|
Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock
|
|
Aug 7
|
Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises'
|
|
Aug 7
|
Insulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Aug 7
|
Insulet beats second-quarter profit estimates on strong demand for insulin pumps
|
|
Aug 7
|
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 7
|
Insulet: Q2 Earnings Snapshot
|
|
Aug 7
|
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
|
|
Aug 6
|
Insulet (PODD) Q2 Earnings: What To Expect
|
|
Aug 5
|
Curious about Insulet (PODD) Q2 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Jul 31
|
Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Jul 30
|
QualiZeal Welcomes Healthcare Industry Visionary Dr. Aiman Abdel-Malek to Business Advisory Board
|
|
Jul 24
|
10x Genomics Stock Earns RS Rating Upgrade
|
|
Jul 24
|
What to Expect From Insulet's Q2 2025 Earnings Report
|
|
Jul 17
|
Should You Be Adding Insulet (NASDAQ:PODD) To Your Watchlist Today?
|
|
Jul 1
|
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
|
|
Jul 1
|
Apple AI, Wolfspeed bankruptcy, medical device stocks
|
|
Jul 1
|
Medical device maker stocks falls after proposed Medicare payment cuts
|